Intravesical Instillation with Vivo-Morpholino Nerve Growth Factor Antisense Therapy Ameliorates Acute Interstitial Cystitis/Painful Bladder Syndrome-Related Urinary Frequency in a Rat Model
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06394-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Yung-Hsiang Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, 40402, Taiwan. Hauptthemen laut MEDLINE: Nerve Growth Factor, Cystitis, Interstitial, Oligonucleotides, Antisense, Morpholinos. Die Arbeit nennt 44 Literaturangaben. Gefördert von: China Medical University Hospital, China Medical University, Taiwan, National Science and Technology Council.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Increased nerve growth factor (NGF) expression in the bladder is known to contribute to the hyperexcitability of C-fiber bladder afferent pathways in interstitial cystitis/painful bladder syndrome (IC/PBS). We hypothesized that intravesical administration of vivo-morpholino NGF antisense oligonucleotide (OND) would downregulate NGF expression and alleviate IC/PBS-associated urinary frequency. METHODS: Eighteen virgin female rats were randomly divided into three groups: (1) saline-injected control, (2) cyclophosphamide (CYP) plus intravesical instillation with normal saline, and (3) CYP plus intravesical instillation with vivo-morpholino NGF antisense OND (2 mg/kg). Female rats received an intravesical instillation of vivo-morpholino NGF antisense oligonucleotide once daily for three consecutive days, with a 30-min dwell time. Cystometric and histological evaluations were performed 24 h after the last instillation. Cystometry was used to evaluate voiding interval values under anesthesia, while NGF expression was measured. RESULTS: Immunohistochemistry demonstrated a ~ 26% increase in bladder NGF expression in CYP-induced IC/PBS rats compared with controls, particularly in the urothelium and suburothelium, whereas intravesical NGF antisense therapy reduced NGF levels by ~ 28%, approaching control values. Cystometric analysis revealed that CYP treatment reduced voiding intervals by ~ 61% at 24 h and ~ 40% at 48 h compared to controls, consistent with bladder overactivity. NGF antisense therapy markedly prolonged voiding intervals, increasing them by ~ 113% at 24 h and ~ 80% at 48 h compared with CYP, indicating progressive functional improvement. Baseline and maximal bladder pressures were not significantly different among groups. CONCLUSIONS: Intravesical administration of vivo-morpholino NGF antisense OND significantly prolonged voiding intervals and attenuated bladder NGF expression in CYP-induced acute IC/PBS female rats. These results highlight the potential of NGF antisense OND as a novel intravesical therapy for IC/PBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, 40402, Taiwan.
- Departments of Medical Research, Urology, and Obstetrics and Gynecology, China Medical University Hospital, Taichung, 40402, Taiwan.
- Department of Psychology, College of Medical and Health Science, Asia University, Taichung, 41354, Taiwan.
- Department of Respiratory Therapy, College of Medicine, Department of Medical Research, Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan.
- Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, No. 91, Hsueh-Shih Road, Taichung, 40402, Taiwan. d888208@ms45.hinet.net.
- Departments of Medical Research, Urology, and Obstetrics and Gynecology, China Medical University Hospital, Taichung, 40402, Taiwan. d888208@ms45.hinet.net.
Förderung
- China Medical University Hospital
- China Medical University, Taiwan
- National Science and Technology Council
Zitieren
APA
Chen, Y. H., Chen, W. C., Liu, P. L., & Chen, H. Y. (2025). Intravesical Instillation with Vivo-Morpholino Nerve Growth Factor Antisense Therapy Ameliorates Acute Interstitial Cystitis/Painful Bladder Syndrome-Related Urinary Frequency in a Rat Model. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06394-6
Vancouver
Chen YH, Chen WC, Liu PL, Chen HY. Intravesical Instillation with Vivo-Morpholino Nerve Growth Factor Antisense Therapy Ameliorates Acute Interstitial Cystitis/Painful Bladder Syndrome-Related Urinary Frequency in a Rat Model. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06394-6
BibTeX
@article{Chen2025,
author = {Chen, Yung-Hsiang and Chen, Wen-Chi and Liu, Po-Len and Chen, Huey-Yi},
title = {Intravesical Instillation with Vivo-Morpholino Nerve Growth Factor Antisense Therapy Ameliorates Acute Interstitial Cystitis/Painful Bladder Syndrome-Related Urinary Frequency in a Rat Model},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06394-6}
}
EUVIMED